Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia

Citation
T. Ohnuma et al., Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia, NEUROREPORT, 11(14), 2000, pp. 3133-3137
Citations number
23
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROREPORT
ISSN journal
09594965 → ACNP
Volume
11
Issue
14
Year of publication
2000
Pages
3133 - 3137
Database
ISI
SICI code
0959-4965(20000928)11:14<3133:GEOPIP>2.0.ZU;2-N
Abstract
A number of studies have suggested that disturbance in glutamatergic transm ission in the cerebral cortex may underlie, or contribute to the pathophysi ology of schizophrenia. In this study we examined expression of the postsyn aptic density protein 95 (PSD95) mRNA in the prefrontal cortex and hippocam pus in postmortem material from neuroleptic-treated schizophrenics and norm al controls. PSD95 is known to bind to NMDA receptor subunits and is known to be involved in synaptic plasticity. In situ hybridization analysis showe d that the expression of PSD95 was significantly decreased in Brodmann area 9 of the prefrontal cortex but not in the hippocampus. These results furth er implicate the prefrontal cortex in the pathophysiology of schizophrenia and suggest dysfunction of NMDA receptors in the schizophrenic cortex. Neur oReport 11:3133-3137 (C) 2000 Lippincott Williams & Wilkins.